Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Quattro74on May 16, 2020 9:41am

141 Views

Post# 31037586

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SRNE - Sorrento Therapeutics Inc.

One thing is priced in, the pandemic. It has devistated small caps. Any progress there, antibody treatment or early vaccine available and we're trading back in the .40s IMO :-)

LaserStock29 wrote:

fredgoodwinson wrote: Tend to agree Skier that the IND (and we haven`t got one yet!) is not priced in at our meagre market cap.

Nothing is priced in. Not results. Not IND absolutely zero orf research for GBM or Lung.............I cant wait till medtronic finishes their Navablate trial august 31. Using heat to ablate lung tumours.. yep the global partner we need. Imho. Anyhow what is the IND worth. A quick .40c candy store job or a trip to the factory $1 admission.